APA (7th ed.) Citation

Ardakani, K. Y., Passarella, G., Lania, A. G. A., Clementi, T. D., Fanti, A., Pepe, F. F., . . . Cazzaniga, M. E. (2026). Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review. Current Oncology, 31(1), 28. https://doi.org/10.3390/curroncol33010028

Chicago Style (17th ed.) Citation

Ardakani, Khashayar Yazdanpanah, Gaia Passarella, Andrea Gerardo Antonio Lania, Thoma Dario Clementi, Alessandro Fanti, Francesca Fulvia Pepe, Serena Capici, and Marina Elena Cazzaniga. "Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review." Current Oncology 31, no. 1 (2026): 28. https://doi.org/10.3390/curroncol33010028.

MLA (9th ed.) Citation

Ardakani, Khashayar Yazdanpanah, et al. "Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review." Current Oncology, vol. 31, no. 1, 2026, p. 28, https://doi.org/10.3390/curroncol33010028.